Posts Tagged ‘CARB-X’
CARB-X is funding UK-biotech GenomeKey to develop a rapid diagnostic for sepsis, a leading cause of death in hospitals
(BOSTON) – CARB-X is awarding SETsquared Bristol member, GenomeKey (Genomics Labs Ltd.) in Bristol, UK, up to $9.5 million in grant funding to develop an innovative rapid diagnostic for sepsis. The new diagnostic would significantly reduce the time it takes to determine what bacteria are causing an infection and which antibiotics would be most effective…
Read More